Cargando…

Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection

Both dual time-point (99m)Tc-hexamethylpropylene amine oxime (HMPAO)-leukocyte scintigraphy and dual-tracer (99m)Tc-HMPAO-leukocyte scintigraphy (with the addition of (99m)Tc-nanocolloid bone marrow scintigraphy) have been used to diagnose prosthetic joint infection (PJI). A treatment evaluation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Teiler, Johan, Åkerlund, Börje, Brismar, Harald, Savitcheva, Irina, Ahl, Marcus, Bjäreback, Annie, Hedlund, Håkan, Holstensson, Maria, Axelsson, Rimma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191474/
https://www.ncbi.nlm.nih.gov/pubmed/33741868
http://dx.doi.org/10.1097/MNM.0000000000001403
_version_ 1783705877193162752
author Teiler, Johan
Åkerlund, Börje
Brismar, Harald
Savitcheva, Irina
Ahl, Marcus
Bjäreback, Annie
Hedlund, Håkan
Holstensson, Maria
Axelsson, Rimma
author_facet Teiler, Johan
Åkerlund, Börje
Brismar, Harald
Savitcheva, Irina
Ahl, Marcus
Bjäreback, Annie
Hedlund, Håkan
Holstensson, Maria
Axelsson, Rimma
author_sort Teiler, Johan
collection PubMed
description Both dual time-point (99m)Tc-hexamethylpropylene amine oxime (HMPAO)-leukocyte scintigraphy and dual-tracer (99m)Tc-HMPAO-leukocyte scintigraphy (with the addition of (99m)Tc-nanocolloid bone marrow scintigraphy) have been used to diagnose prosthetic joint infection (PJI). A treatment evaluation of persistent PJI using these imaging protocols has yet to be presented. OBJECTIVE: The purpose of this study was to compare the accuracy of dual time-point (99m)Tc-HMPAO-leukocyte scintigraphy to the dual-tracer alternative of single time-point (99m)Tc-HMPAO-leukocyte scintigraphy or single-photon emission computed tomography/computed tomography (SPECT/CT) combined with a (99m)Tc-nanocolloid bone marrow scintigraphy or SPECT/CT, for treatment evaluation of PJI. MATERIAL AND METHODS: Thirty-one PJI patients under antibiotic treatment were included in this retrospective study. Examinations were organized into three settings. Setting one used dual time-point approach with delayed (2 h) and late (24 h) planar (99m)Tc-HMPAO-leukocyte scintigraphy, including both visual and semiquantitative analysis. Setting two used delayed (2 h) planar (99m)Tc-HMPAO-leukocyte scintigraphy combined with (99m)Tc-nanocolloid bone marrow scintigraphy and for setting three SPECT/CT replaced planar imaging. RESULTS: Accuracy was 0.68 for visual evaluation and 0.55 for semiquantitative evaluation of setting one; 0.71 for setting two; and 0.68 for setting three. Sensitivity was 0.54 for visual evaluation and 0.31 for semiquantitative evaluation of setting one; 0.38 for setting two; and 0.46 for setting three. Specificity was 0.78 for visual evaluation and 0.72 for semiquantitative evaluation of setting one; 0.94 for setting two; and 0.83 for setting three. CONCLUSION: No significant difference in accuracy, sensitivity, or specificity between the approaches for treatment evaluation of suspected persistent PJI in the hip or knee was observed.
format Online
Article
Text
id pubmed-8191474
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-81914742021-06-16 Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection Teiler, Johan Åkerlund, Börje Brismar, Harald Savitcheva, Irina Ahl, Marcus Bjäreback, Annie Hedlund, Håkan Holstensson, Maria Axelsson, Rimma Nucl Med Commun Original Articles Both dual time-point (99m)Tc-hexamethylpropylene amine oxime (HMPAO)-leukocyte scintigraphy and dual-tracer (99m)Tc-HMPAO-leukocyte scintigraphy (with the addition of (99m)Tc-nanocolloid bone marrow scintigraphy) have been used to diagnose prosthetic joint infection (PJI). A treatment evaluation of persistent PJI using these imaging protocols has yet to be presented. OBJECTIVE: The purpose of this study was to compare the accuracy of dual time-point (99m)Tc-HMPAO-leukocyte scintigraphy to the dual-tracer alternative of single time-point (99m)Tc-HMPAO-leukocyte scintigraphy or single-photon emission computed tomography/computed tomography (SPECT/CT) combined with a (99m)Tc-nanocolloid bone marrow scintigraphy or SPECT/CT, for treatment evaluation of PJI. MATERIAL AND METHODS: Thirty-one PJI patients under antibiotic treatment were included in this retrospective study. Examinations were organized into three settings. Setting one used dual time-point approach with delayed (2 h) and late (24 h) planar (99m)Tc-HMPAO-leukocyte scintigraphy, including both visual and semiquantitative analysis. Setting two used delayed (2 h) planar (99m)Tc-HMPAO-leukocyte scintigraphy combined with (99m)Tc-nanocolloid bone marrow scintigraphy and for setting three SPECT/CT replaced planar imaging. RESULTS: Accuracy was 0.68 for visual evaluation and 0.55 for semiquantitative evaluation of setting one; 0.71 for setting two; and 0.68 for setting three. Sensitivity was 0.54 for visual evaluation and 0.31 for semiquantitative evaluation of setting one; 0.38 for setting two; and 0.46 for setting three. Specificity was 0.78 for visual evaluation and 0.72 for semiquantitative evaluation of setting one; 0.94 for setting two; and 0.83 for setting three. CONCLUSION: No significant difference in accuracy, sensitivity, or specificity between the approaches for treatment evaluation of suspected persistent PJI in the hip or knee was observed. Lippincott Williams & Wilkins 2021-03-12 2021-07 /pmc/articles/PMC8191474/ /pubmed/33741868 http://dx.doi.org/10.1097/MNM.0000000000001403 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Articles
Teiler, Johan
Åkerlund, Börje
Brismar, Harald
Savitcheva, Irina
Ahl, Marcus
Bjäreback, Annie
Hedlund, Håkan
Holstensson, Maria
Axelsson, Rimma
Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection
title Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection
title_full Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection
title_fullStr Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection
title_full_unstemmed Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection
title_short Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection
title_sort dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191474/
https://www.ncbi.nlm.nih.gov/pubmed/33741868
http://dx.doi.org/10.1097/MNM.0000000000001403
work_keys_str_mv AT teilerjohan dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection
AT akerlundborje dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection
AT brismarharald dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection
AT savitchevairina dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection
AT ahlmarcus dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection
AT bjarebackannie dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection
AT hedlundhakan dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection
AT holstenssonmaria dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection
AT axelssonrimma dualtracerapproachvsdualtimepointapproachinleukocytescintigraphyintreatmentevaluationofpersistentchronicprostheticjointinfection